Health ❯Healthcare ❯Pharmaceuticals

Weight Loss

Wegovy Semaglutide Clinical Trials Obesity Treatments GLP-1 Drugs GLP-1 Receptor Agonists Zepbound Amycretin Tirzepatide Hormonal Treatments Medication Efficacy Mounjaro Ozempic Compounded Medications Anti-Obesity Medications GLP-1 Medications Anti-Obesity Drugs Drug Comparison Cagrisema CagriSema Online Purchases Orforglipron GLP-1 Injections Drug Pricing

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Super Bowl Ad for Compounded Weight Loss Drugs Draws Criticism Over Safety and Regulation

Warnings Issued Over Unsafe Online Sales of Weight-Loss Injections

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Eli Lilly Partners with Ro to Expand Access to Lower-Cost Zepbound Vials

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

NHS to Gradually Roll Out Mounjaro Weight-Loss Drug Over 12 Years

UK Regulators Warn Against Misuse of Weight-Loss Injections

Doctors Question Safety and Efficacy of GLP-1 Supplements and Drugs for Weight Loss

New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs

Study Identifies Key Factors Influencing Weight Loss on GLP-1 RA Medications

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients